NCT06529185
Effect of Breather in COPD Patients With Intermittent Claudication
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Notable Enrollment target: 40 to 60
- Eligibility criteria shortened, about 1 word
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
- Study sites: 0 to 1
- Primary completion date: Jan 2025 to Dec 20, 2024
- Study completion date: Mar 2025 to Feb 2025
- Start date changed from estimate of Aug 2024 to Jul 30, 2024
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (2)
Arms and interventions
This group include 30 patients with COPD and intermittent claudication. These patients can receive aerobic exercise (by applying treadmill exercise for 20 min) and inspiratory muscle training (by using The BREATHER device with Light/Medium resistance for 3-5 sets /session), for 4 weeks (3 sessions per week) and pursed lip breathing.
This group include 30 patients with COPD and intermittent claudication. These patients can receive pursed lip breathing and aerobic exercise (by applying treadmill exercise for 20 min) with the usually pharmacological treatment, for 4 weeks (3 sessions per week).
Devices: The BREATHER
Drugs: pharmacological treatment
Sites
1 site in 1 country
- Faculty of Physical TherapyDokki, Egypt